Teladoc Health Inc. [TDOC] CHIEF PEOPLE OFFICER makes an insider sale of 527 shares worth 15,575.

0
2

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Teladoc Health Inc. shares valued at $15,575 were sold by Geshuri Arnnon on Oct 31. At $29.55 per share, Geshuri Arnnon sold 527 shares. The insider’s holdings dropped to 76,715 shares worth approximately $2.13 million following the completion of this transaction.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Also, Trencher Daniel sold 1,000 shares, netting a total of over 24,040 in proceeds. Following the sale of shares at $24.04 each, the insider now holds 24,408 shares.

Before that, Napolitano Richard J had sold 220 shares from its account. In a trade valued at $6,084, the CHIEF ACCOUNTING OFFICER traded Teladoc Health Inc. shares for $27.65 each. Upon closing the transaction, the insider’s holdings decreased to 220 shares, worth approximately $43686.72.

As published in a research note from Guggenheim on October 24, 2022, Teladoc Health Inc. [TDOC] has been rated up from a Sell to a Neutral. Analysts at KeyBanc Capital Markets started covering the stock with ‘”a Sector weight”‘ outlook in a report released in mid September. As of September 07, 2022, Truist has initiated its “Hold” rating for TDOC. Earlier on August 17, 2022, Guggenheim downgraded its rating. Their new recommendation was “a Sell” for TDOC stock which previously was a “a Neutral”.

Analyzing TDOC Stock Performance

On Thursday, Teladoc Health Inc. [NYSE: TDOC] plunged -1.14% to $27.72. The stock’s lowest price that day was $26.73, but it reached a high of $28.22 in the same session. During the last five days, there has been a drop of approximately -2.63%. Over the course of the year, Teladoc Health Inc. shares have dropped approximately -69.81%. Shares of the company reached a 52-week high of $95.71 on 01/04/22 and a 52-week low of $23.08 on 10/14/22. A 50-day SMA is recorded $28.21, while a 200-day SMA reached $44.89. Nevertheless, trading volume fell to 4.06 million shares from 3.71 million shares the previous day.

Support And Resistance Levels for Teladoc Health Inc. (TDOC)

According to the 24-hour chart, there is a support level at 26.89, which, if violated, would cause prices to drop to 26.07. In the upper region, resistance lies at 28.38. The next price resistance is at 29.05. RSI (Relative Strength Index) is 52.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.59, which suggests the price will increase in the coming days. Percent R is at 39.37%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Teladoc Health Inc. subject to short interest?

Stocks of Teladoc Health Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -3.35 million shares to 33.3 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 36.65 million shares. A decline of -10.06% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.24 of the overall float, the days-to-cover ratio (short ratio) decline to 6.24.

Which companies own the most shares of Teladoc Health Inc. (TDOC)?

According to ARK Investment Management LLC filings, the company currently owns 20,858,302 shares, which is about 12.90% of the total TDOC shares outstanding. The investor’s shares have appreciated by 564,340 from its previous 13-F filing of 20293962.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $335,334,338. Nikko Asset Management Co., Ltd. reduced a -1.41% interest valued at $218.0 million while Nikko Asset Management Americas, sold a -163,361 stake. A total of 573,671 shares of Teladoc Health Inc. were sold by BlackRock Fund Advisors during the quarter, and -2,494,623 were sold by Baillie Gifford & Co. In its current portfolio, Renaissance Technologies LLC holds 4,475,319 shares valued at $113.45 million.

In spite of this, 32 analysts ranked Teladoc Health Inc. stock as a Hold at the end of 2022. On August 12, 2022, DA Davidson assigned a price target of “a Buy” to the stock and initiated coverage with a $45.

LEAVE A REPLY

Please enter your comment!
Please enter your name here